RPS26P28

Across TCGA pan-cancer cohorts, RPS26P28 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated RPS26P28 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS26P28 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS26P28 expression acts as an unfavorable survival marker, although some lineages such as READ and OV show a favorable association.

ACC, READ, and UVM are the cancer types where RPS26P28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.407	0.809	.001	68	view →
READ	DFS	Tertile	II,III,IV	0.958	0.577	.002	48	view →
UVM	DFS	Quartile	All	0.477	0.941	.009	37	view →
MESO	OS	Quartile	All	0.236	0.474	.006	36	view →
LIHC	DFS	Quartile	All	0.175	0.363	.001	33	view →
PAAD	DFS	Tertile	All	0.192	0.430	.003	27	view →
OV	DFS	Quartile	III,IV	0.214	0.135	.017	22	view →
COAD	DFS	Quartile	All	0.859	0.559	.001	21	view →
KIRP	OS	Median	All	0.560	0.816	<.001	20	view →
SKCM	OS	Tertile	III,IV	0.701	0.314	<.001	19	view →
BLCA	DFS	Quartile	III,IV	0.676	0.285	<.001	19	view →
UCEC	OS	Quartile	IV	0.332	0.756	.008	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 28 lineages.

RPS26P28–ACC (OS)

Open the ACC breakdown →